Evoq Remedies News

Evog Remedies Promoter Bhumishth Patel Sells 5.36 Lakh Shares

Bhumishth Narendrabhai Patel, a promoter of Evog Remedies Limited, disposed of 5,36,000 equity shares on October 21, 2025, through stock exchange transactions. The sale represents 2.15% of the company's total share capital. Following the disposal, Patel's shareholding decreased from 5,39,574 shares to 3,574 shares. The company has an equity share capital of 2,49,00,000 shares of Rs. 10 each, totaling Rs. 24.90 crores. The disclosure was made under SEBI regulations for substantial acquisition of shares and takeovers.

Evoq Remedies Reports Mixed Half-Year Results Amid SEBI Investigation and Compliance Issues

Evoq Remedies Limited reported revenue from operations of ₹1,175.67 lakhs for the half-year ended September 30, 2025, with a profit after tax of ₹5.43 lakhs. The company's total assets increased to ₹5,221.50 lakhs from ₹5,000.94 lakhs in March 2025. However, the company faces significant regulatory challenges including a SEBI investigation into financial statements and a show cause notice regarding ₹9.21 crore raised through preferential allotment. The auditor's review report highlighted multiple compliance failures including non-implementation of mandatory audit trail software, unconfirmed advances to suppliers worth ₹1,250.87 lakhs, outstanding GST demand of ₹655.03 lakhs, disputed income tax demands of ₹39.99 lakhs, and non-compliance with various provisions of the Companies Act 2013. The company operates in agro commodity trading and has a paid-up share capital of ₹2,490 lakhs.